Work

Pd25-07 Final Results of a Phase Ii Trial of Bacillus Calmette-guérin (bcg) and Intravesical Gemcitabine for Patients With Bcg-exposed High-grade Non-muscle Invasive Bladder Cancer (nct04179162)